The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Onychomycosis Treatment Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The onychomycosis treatment market size has experienced significant growth in recent years. It is projected to increase from $3.91 billion in 2025 to $4.16 billion in 2026, registering a compound annual growth rate (CAGR) of 6.5%. The expansion observed in the historic period was influenced by factors including the high prevalence of onychomycosis, the limited availability of advanced antifungal drugs, growing public awareness regarding nail hygiene, an escalating demand for topical antifungal treatments, and an uptick in fungal infections within the elderly population.
The onychomycosis treatment market is projected to experience substantial expansion over the upcoming years, reaching $5.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This projected growth can be linked to several factors, including advancements in laser and photodynamic therapy technologies, a greater uptake of combined treatment strategies, an increase in telemedicine consultations for dermatological conditions, the broadening reach of hospital and retail pharmacy distribution, and intensified research and development efforts targeting drug-resistant fungal strains. Key trends anticipated during this period encompass a rise in the use of combined drug and laser therapies, expanded application of photodynamic therapy for persistent infections, heightened public awareness concerning preventive nail care, the increasing deployment of AI-powered diagnostic tools for fungal infections, and a surge in telemedicine usage for managing onychomycosis.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12941&type=smp
Which Growth Factors Are Strengthening The Onychomycosis Treatment Market Landscape?
The escalating incidence of fungal infections is projected to propel the expansion of the onychomycosis treatment market in the coming period. Fungal infections are microbial ailments caused by various fungi, capable of affecting different body parts or leading to specific conditions. Onychomycosis, which is a fungal infection of the nail, is commonly managed with oral antifungal medications or topical antifungal solutions aimed at eliminating the underlying fungal proliferation and restoring healthy nail growth. For instance, the UK Health Security Agency, a UK-based government body, reported in May 2025 that the rate of bloodstream infections due to yeasts across England had increased by 31% since 2015 and by 4% from 2023, as of 2024. Additionally, between 2023 and 2024, the number of laboratory reports for fungemia caused by yeasts in England rose by 4% (from 2,170 to 2,247 reports). Therefore, the rising occurrence of fungal infections is acting as a key driver for the growth of the onychomycosis treatment market.
Which Segment Groups Define The Onychomycosis Treatment Market Landscape?
The onychomycosis treatment market covered in this report is segmented –
1) By Type: Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Candida Onychomycosis, Other Types
2) By Treatment Type: Drugs, Laser Therapy, Photodynamic Therapy
3) By Age Group: 0 To 18 Years, 18 To 39 Years, 40 To 64 Years, 65 Years And Above
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
Which Trends Are Expected To Shape The Onychomycosis Treatment Market?
Leading companies in the onychomycosis market are engaged in developing innovative product formulations to maintain their market position. These novel formulations contribute to the advancement of the onychomycosis market by improving treatment outcomes and addressing specific challenges related to the condition. For example, in February 2024, Moberg Pharma AB, a pharmaceutical company based in Sweden, launched MOB-015. This is a proprietary topical formulation of terbinafine designed to deliver effective concentrations directly to the nail and nail bed, thereby minimizing the risk of systemic exposure associated with oral terbinafine. It has received recommendations for national approval in 13 European countries and is sold in Sweden under the brand name Terclara. The approval is supported by two Phase 3 trials, which indicated that MOB-015 achieved superior mycological cure rates (76% compared to up to 42% for comparators) and a significantly higher complete cure rate with no serious adverse reactions reported.
Who Are The Businesses Driving Activity In The Onychomycosis Treatment Market?
Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd.
Access The Complete Onychomycosis Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report
Which Regional Market Leads The Onychomycosis Treatment Market?
North America was the largest region in the onychomycosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Onychomycosis Treatment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12941&type=smp
Browse Through More Reports Similar to the Global Onychomycosis Treatment Market 2026, By The Business Research Company
Onychomycosis Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/onychomycosis-treatment-global-market-report
Systemic Aspergillosis And Systemic Candidiasis Global Market Report 2026
Invasive Fungal Infections Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/invasive-fungal-infections-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model